Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Daiichi Sankyo
McKesson
Citi
Cipla
Moodys
Accenture
Fish and Richardson

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080044

« Back to Dashboard

NDA 080044 describes PROPOXYPHENE COMPOUND 65, which is a drug marketed by Ivax Sub Teva Pharms, Sandoz, and Teva, and is included in three NDAs. Additional details are available on the PROPOXYPHENE COMPOUND 65 profile page.

The generic ingredient in PROPOXYPHENE COMPOUND 65 is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for 080044
Tradename:PROPOXYPHENE COMPOUND 65
Applicant:Sandoz
Ingredient:aspirin; caffeine; propoxyphene hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength389MG;32.4MG;65MG
Approval Date:Sep 16, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Cipla
Cerilliant
Chubb
US Army
Covington
QuintilesIMS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.